Epithelial and Stromal Cathepsin K and CXCL14 Expression in Breast Tumor Progression.

Epithelial and Stromal Cathepsin K and CXCL14 Expression in Breast Tumor Progression. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Epithelial and Stromal Cathepsin K and CXCL14 Expression in Breast Tumor Progression. Abstract Text:

PURPOSE: To evaluate the expression of cathepsin K (CTSK) and CXCL14 in stromal and epithelial cells in human breast tumor progression. EXPERIMENTAL DESIGN: We did immunohistochemical analyses of CTSK and CXCL14 expression in normal breast tissue, biopsy sites, benign lesions, ductal carcinoma in situ, and invasive breast tumors of different stages. Expression patterns were related to histopathologic characteristics of the tumors and clinical outcome. The effect of CTSK+ breast stromal fibroblasts on CTSK- breast cancer cells was assessed in coculture. RESULTS: Epithelial expression of CTSK was rarely detected in any of the tissue samples analyzed, whereas CXCL14-positive epithelial cells were found in all tissue types. The expression of CXCL14 was not associated with any tumor or patient characteristics analyzed. Stromal CTSK expression was significantly higher in invasive compared with in situ carcinomas, and in one of the two data sets analyzed, it correlated with higher tumor stage. Among all samples examined, the highest stromal CTSK levels were detected in biopsy sites. Neither epithelial nor stromal expression of CTSK was significantly associated with recurrence-free or overall survival. Coculture of CTSK+ fibroblasts enhanced the invasion of CTSK- breast tumor epithelial cells and this was blocked by CTSK inhibitors. CONCLUSIONS: CTSK may function as a paracrine factor in breast tumorigenesis. CTSK+ fibroblasts may play a role in tumor progression by promoting the invasiveness of tumor epithelial cells. The possibility that CTSK inhibitors may have a clinical role in decreasing the risk of tumor progression merits further investigation.

Epithelial and Stromal Cathepsin K and CXCL14 Expression in Breast Tumor Progression. Publishing Authors By Initials

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Epithelial and Stromal Cathepsin K and CXCL14 Expression in Breast Tumor Progression. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Clinical cancer research : an official journal of

VOLUME: 14

Page Numbers: 5357-67

Journal Abbreviation: Clin. Cancer Res.

ISSN: 1078-0432

DAY: 1

MONTH: Sep

YEAR: 2008

Epithelial and Stromal Cathepsin K and CXCL14 Expression in Breast Tumor Progression. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9502500

Epithelial and Stromal Cathepsin K and CXCL14 Expression in Breast Tumor Progression. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Epithelial and Stromal Cathepsin K and CXCL14 Expression in Breast Tumor Progression. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Epithelial and Stromal Cathepsin K and CXCL14 Expression in Breast Tumor Progression.

AFFILIATION: Authors' Affiliations: Departments of Pathology and Surgery, University of Michigan Cancer Center, Ann Arbor, Michigan; Departments of Medical Oncology and Biostatistics and Computational Biology, Dana-Farber Cancer Institute.

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Clin Cancer Res

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Epithelial and Stromal Cathepsin K and CXCL14 Expression in Breast Tumor Progression Related Publications

• Arbidol: A Broad-Spectrum Antiviral Compound that Blocks Viral Fusion.
• Artifactual detection of biotin on histones by streptavidin.
• Biochemical mechanism of hepatitis C virus inhibition by the broad-spectrum antiviral arbidol.
• Breast cancer stem cells: a case of mistaken identity?
• Breast cancer: origins and evolution.
• Breast tumor heterogeneity: cancer stem cells or clonal evolution?
• Cell type-specific DNA methylation patterns in the human breast.
• Epithelial and Stromal Cathepsin K and CXCL14 Expression in Breast Tumor Progression.
• FMC7 is an epitope of CD20.
• Is breast tumor progression really linear?
• Methylation-specific digital karyotyping.
• Microbial biotin protein ligases aid in understanding holocarboxylase synthetase deficiency.
• Microenvironmental regulation of cancer development.
• Reduced half-life of holocarboxylase synthetase from patients with severe multiple carboxylase deficiency.
• Regulation of CXCL-8 (interleukin-8) induction by double-stranded RNA signaling pathways during hepatitis C virus infection.
• Regulation of in situ to invasive breast carcinoma transition.
• The cancer stem cell hypothesis: in search of definitions, markers, and relevance.
• [Daily variation in intraocular pressure.]